Therapeutic Biologics Research
Exponential power to engineer novel therapeutics
From early discovery through development, MindWalk integrates Bio-Native AI, deep data, and advanced lab research into a customizable ecosystem engineered to support precision, deepen diversity, and enable confident discovery.
Workflows built for complex discovery
Contributed to 20+ client molecules advancing to clinic
Precision biologic insight driven by AI, data, and advanced lab research—designed to bring blind spots into view and support complex discovery programs.
Continuity, seamless handoffs
One workflow bridging target analysis to IND-enabling readiness
Stronger starts
Risk considerations brought forward early to help avoid costly late-stage surprises
360° intelligence with transparent insight
Powered by LensAI™, integrated biological and functional data provide a transparent, explainable view of each candidate’s strengths and areas of uncertainty
A customizable ecosystem
No two programs are alike. Our approach adapts to your challenges with diversity-driven workflows designed to surface rare candidates with strong translational potential and support more targeted experimental design.
One system + Connected intelligence + Transformative insight
Speed
- Stronger starts
- Reduced time to lead selection
Integrated workflows help flag areas of potential risk earlier
Speed
- Stronger starts
- Reduced time to lead selection
Integrated workflows help flag areas of potential risk earlier
Diversity
- Rare, high-value candidates brought into focus
- Deep insight across phenotypic diversity highlights patterns not visible in isolated data
Broad, connected datasets add depth—revealing opportunities across discovery programs
Confidence
- Evidence-based discovery
- >98% B cell Select® success rate*
Deep biological data and predictive modeling bring risk considerations forward
*“Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Revealing what was once unseen
Every discovery holds hidden biologic patterns that reveal what to pursue, refine, or reimagine. MindWalk integrates intelligent analysis with experimental depth to interpret those patterns—an approach designed to support the development of differentiated therapeutic candidates.
Your success is our success
Collaboration drives every project. We listen, adapt, and align with your goals, applying scientific and technological rigor with advanced workflows to deliver reliable insights and support progress. For us, success is measured by the progress of your discoveries.
“LensAI solves a foundational problem—making biological data interoperable and accessible at scale. It brings context into view, giving us the kind of resolution you’d expect from modern data systems—and that changes everything.” - Jeff Fried, Advisory Board Member, MindWalk
Where our research makes a broad impact
Oncology + Infectious Disease + Neurodegeneration + Metabolic Disease + Rare Disease + Inflammation + Market Kits
Biologics discovery across complex targets
Contributed to 20+ client molecules advancing to the clinic
End-to-end antibody discovery + development
LensAI Bio-Native Suite:
- HYFT Base™ Data Integration and Insights: Target Profiling, Off-target & Cross-reactivity, Antigen Design, Epitope Prediction, Epitope Specificity Analysis, Protein Structure Prediction, GMX (MD Applications)
- HYFT Matrix™ Exploration Layer: Epitope Mapping, Affinity Predictions (MD), Hit Selection, Developability Assessment, Immunogenicity Screening, Hit Expansion
- HYFT Prime™ Engineering and Design Engine: Humanization, De-risk Engineering, Binding Affinity Optimization, Target Specificity and Selectivity
Integrated Therapeutic Discovery AI | Data | Lab:
Target
- Target Analysis
- Tool Generation
- HYFT Base
Discovery
- Immunization Strategies
- B cell Select® Antibody Discovery
- Hybridoma Antibody Discovery
- Yeast Display Antibody Discovery
- B cell Llama™ VHH Antibody Discovery
- De novo Design
- HYFT Matrix & HYFT Prime
Leads
- Lead Characterization
- Lead Optimization
- Protein Engineering and Production
- HYFT Matrix & HYFT Prime
Candidate Selection
- Research Cell Bank Generation
Functional selection
- Internalization
- Neutralization
- Epitope Mapping
- Affinity, Specificity, Developability
- Custom Cell-based and Plate-based Assays
Species Diversity
Rabbit + Chicken + Camelid + Mice
Immunization Strategies
Protein + Genetic + Peptide + Whole Cell
Format Options
- Full-length IgG
- Bispecific Antibodies (bsAbs)
- VHH Single-Domain Camelid
- scFv, Fab, F(ab’)2
- Custom Formats
- Fusion Constructs
Explore wet lab antibody discovery technologies in more depth. Learn how individual antibody discovery technologies, function-first screening, end-to-end discovery workflows, and integrated AI analysis help discovery teams support biologics programs. Learn more
Expanding discovery innovation
Vaccines + Peptide Therapies + Cell Therapies + Other Biologics
Let’s shape the future
One biointelligent ecosystem,
explore partnership opportunities
Used by teams across 19 of the top 20 pharma companies, next-gen biotechs, and top research institutions.
Talk 1:1 with the team
Let’s expand what’s possible for human health
Four ways to access MindWalk
We build it
Customizable offerings in biologics discovery—from target analysis to optimized leads.
You build it
Access to state-of-the-art LensAI SaaS Platform.
The Vault
Smarter starts: a portfolio of partner-ready assets.
Partnership
We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.
FAQs
-
What should I look for in a therapeutic antibody discovery partner?
A strong therapeutic antibody discovery partner should bring more than a discovery platform. Look for a team that can connect target biology, immunization strategy, functional screening, antibody characterization, developability assessment, protein production, and candidate selection into one development-aware workflow. The right partner should help you identify antibodies with the right biological function, not just binding activity.
-
How does MindWalk support therapeutic antibody discovery?
MindWalk supports the full continuum of therapeutic antibody discovery, from target analysis and antigen design through hit discovery, functional screening, lead characterization, humanization, optimization, and candidate selection. Each program is customized around the target biology, modality, mechanism of action, development path, and candidate diversity goals, including specialized strategies for challenging targets. With broad discovery experience, MindWalk works closely with clients as a scientific partner to help advance antibodies with the right functional and development profile.
-
Does MindWalk support difficult targets or novel mechanisms?
Yes. Difficult targets require workflows built around the biology, not a fixed discovery path. MindWalk works as your scientific partner, bringing more than 30 years of antibody discovery and development experience to complex targets, difficult epitopes, novel mechanisms, and programs with limited biological precedent. Programs can combine wet lab discovery, AI-enabled analysis, functional selection, lead characterization, optimization, protein engineering, production, and candidate selection. MindWalk has contributed to 20+ client molecules that have advanced to the clinic.
-
What does function-first therapeutic antibody discovery mean?
Function-first therapeutic antibody discovery means antibody candidates are evaluated early for biological activity and program-relevant performance, not only for binding affinity. This helps teams assess whether candidates fit the intended mechanism, disease biology, assay context, and downstream therapeutic goals.
-
How does AI improve therapeutic antibody discovery?
AI is most useful when it helps researchers compare antibody candidates across the evidence that matters—not sequence similarity or binding strength alone. MindWalk performs AI-supported antibody discovery and development work, using LensAI™-enabled analysis to evaluate candidates across biological context, structure, function, assay data, developability considerations, immunogenicity considerations, and candidate diversity. These insights can support clearer candidate comparison before optimization, scale-up, or further antibody development.
-
Can MindWalk help optimize lead antibody candidates?
Yes. Lead optimization is where early discovery promise is tested against development reality. MindWalk can support candidate characterization, affinity optimization, developability review, immunogenicity assessment, and wet lab validation to help teams advance stronger candidates with fewer late-stage liabilities.
-
What antibody formats can MindWalk support?
MindWalk supports multiple therapeutic antibody formats, including full-length IgG, bispecific antibodies, VHH/nanobodies, scFv, Fab, F(ab’)2, custom formats, and fusion constructs.
-
Can MindWalk support VHH discovery?
Yes. MindWalk has announced B cell Llama™, a VHH single-domain camelid discovery platform designed for bispecific, multispecific, and cell therapy applications.